查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715838

快速微生物检测市场：2025-2030 年全球预测（按产品、检测方法、样品类型、应用和最终用户）

Rapid Microbiology Testing Market by Product, Testing Method, Sample Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计快速微生物检测市场在 2024 年的价值将达到 48.6 亿美元，到 2025 年将以 7.59% 的复合年增长率增长至 52.2 亿美元，到 2030 年将达到 75.4 亿美元。

主要市场统计数据
基准年2024年 48.6亿美元
预计2025年 52.2亿美元
预测年份 2030 75.4亿美元
复合年增长率（%） 7.59%

快速微生物检测已成为临床诊断、环境安全、工业品管和製药领域的变革力量。在当今快节奏、精准驱动的环境中，及时且准确的微生物检测从未如此重要。微生物学方法的演变不仅仅是一项科学追求，对于寻求降低风险、简化决策和提高生产力的组织来说，它是一项策略必要事项。

本介绍描述了创新微生物技术的起源及其快速应用。加快检测程序的需求既源自于医疗保健领域的新挑战，也源自于环境和工业矩阵日益复杂的变化。技术的快速进步不仅大大缩短了测试时间，而且提高了检测系统的可靠性和灵敏度。本报告深入探讨了这些调查方法的细微差别，并强调了它们的应用和竞争优势。

改进的技术与即时数据分析相结合正在彻底改变微生物学测试的方法。科学技术的融合正在推动向具有成本效益、扩充性的方法的转变，从而使各行各业受益。本入门书将为理解为什么快速微生物学检测在当今充满活力、相互连结的世界中至关重要奠定坚实的基础。

改变快速微生物检测市场

在不断的技术创新和不断变化的市场需求的推动下，快速微生物学检测领域经历了一系列的转变。这项变化的核心是先进仪器和新分析技术的整合，重新定义了我们检测和量化微生物存在的方式。

现代实验室受益于利用自动化系统和人工智慧来简化工作流程的最先进的设备。主动空气采样器和自动微生物鑑定係统对于减少体力劳动和提高产量至关重要。基于生物发光和萤光的检测、细胞分析仪、质谱仪和 PCR 平台等系统在灵敏度和特异性方面设立了新的基准。透过实施这些先进的系统，即使是最小的微生物活动也可以可靠地识别，从而实现更准确的诊断和预防措施。

除了技术进步之外，更广泛的市场正在发生重要的模式转移。对更快、更有效率的测试的需求正在推动产业不断突破极限。市场反应的特征是对研发进行策略性投资，创造一个鼓励和奖励创新的环境。这一转变阶段标誌着向精准医疗和强有力的环境、工业和品质保证通讯协定迈出的更大一步。

实验室营运中数位转型的整合，加上简化的数据分析，使研究人员和从业人员能够做出更明智的决策。这些变化凸显了该行业的动态性质，该行业随着技术进步和市场需求而不断发展。

快速微生物学检测市场的关键细分洞察

对于希望利用快速微生物学检测不断发展的趋势的相关人员来说，全面了解市场区隔至关重要。市场按各个方面进行细分，每个维度都对产品创新、测试技术、特定样品挑战、特定应用和最终用户偏好提供了独特的见解。

依产品分析，市场全面调查耗材、仪器、试剂及试剂套件。具体来说，设备分为几个专门的类别。主动空气采样器、自动微生物鑑定和抗菌敏感性测试系统在快速反应环境中提供关键支援。还有基于生物发光和萤光检测的系统，以及推动微生物分析进步的细胞分析仪和质谱仪。此外，PCR 系统在基因识别和扩增方面发挥着至关重要的作用。

检查方法为分割提供了另一个维度。市场显示出层析法、质谱法和聚合酵素链锁反应技术之间的明显差异。在层析法中，气相层析法和液相层析法分别满足特定的分析需求，而质谱法又进一步细分为基质辅助雷射解吸电离法和飞行时间质谱法，以确保高灵敏度。聚合酵素链锁反应进一步分为数位 PCR 和即时PCR，每种技术均旨在用于微生物检测的不同目的。

基于样本类型的分割突显了背景在微生物分析中的重要性。测试通常在血液、组织和尿液样本上进行，每种样本都有其独特的挑战和要求。这种细分凸显了需要针对每种样本类型的独特属性制定客製化方法，从而最大限度地提高检测准确性并确保结果的稳健性。

基于应用的细分进一步阐明了行业格局，将其分为临床疾病诊断、环境测试、工业测试以及製药和生物技术应用。工业测试专门从事化妆品和个人保健产品测试、食品和饮料测试、药品和生物製药测试。这种多方面的方法确保每个应用程式都按照其各自行业标准所需的精度进行处理。

根据最终用户的最终细分考虑医院、实验室、製造业和公共部门。医院又分为私立医院和公立医院，实验室又包括临床实验室和研究机构。对製造业的分析重点是食品加工商和製药商，反映了快速微生物检测在不同业务模式下的多样化应用。

这种市场区隔洞察提供了对市场的细緻观察，并为市场参与企业提供了蓝图。了解各个细分市场的细微需求使相关人员能够创新并策略性地定位他们的产品和服务。这种详细的细分有助于确定成长领域、了解竞争动态并客製化解决方案以应对每个细分市场的独特挑战。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 快速微生物学检测在感染疾病临床诊断的应用日益增多
      • 在工业和环境测试应用中的快速应用
      • 政府对食品和水检测的严格标准
    • 限制因素
      • 快速微生物检测套组高成本
    • 机会
      • 用于远端医疗和远距离诊断的照护现场快速微生物检测的开发
      • 快速微生物检测整合人工智慧驱动的分析以提高准确性
    • 任务
      • 与快速微生物检测解决方案相关的技术限制
  • 市场区隔分析
    • 测试方法：使用层析法分离化学混合物的现象正在迅速增加
    • 最终用户：扩大医院快速微生物检测的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章快速微生物检测市场（按产品）

  • 耗材
  • 装置
    • 主动空气采样器
    • 自动化微生物鑑定及药敏试验系统
    • 生物发光和萤光检测系统
    • 细胞分析仪
    • 质谱仪
    • PCR体系
  • 试剂和套件

7. 快速微生物检测市场（依检测方法）

  • 层析法
    • 气相层析法
    • 液相层析法
  • 质谱法
    • 基质辅助雷射解吸/电离
    • 飞行时间质谱仪
  • 聚合酵素链锁反应
    • 数位PCR
    • 即时PCR

8. 快速微生物学检测市场（依样本类型）

  • 血
  • 组织
  • 尿

第九章快速微生物检测市场（依应用）

  • 临床疾病诊断
  • 环境测试
  • 工业测试
    • 化妆品和个人保健产品测试
    • 食品和饮料测试
    • 药物和生物测试
  • 製药和生物技术

第 10 章快速微生物学检测市场（按最终用户）

  • 医院
    • 私立医院
    • 公立医院
  • 研究所
    • 临床实验室
    • 研究机构
  • 製造业
    • 食品加工机
    • 製药商
  • 公共部门

第 11 章：美洲快速微生物学检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区快速微生物检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲快速微生物检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析

第 14 章 3.5.透过快速微生物检测加强深度处理：

  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • BTNX Inc.
  • Charles River Laboratories International, Inc.
  • Colifast AS
  • CorDx Inc
  • Danaher Corporation
  • Don Whitley Scientific Limited
  • Gradientech AB
  • Merck KGaA
  • NEOGEN Corporation
  • Paragon Genomics, Inc.
  • PerkinElmer, Inc.
  • Quidel Corporation
  • R-Biopharm AG
  • Rapid Micro Biosystems, Inc.
  • rqmicro AG
  • Sartorius AG
  • Serosep Ltd.
  • Thermo Fisher Scientific, Inc.
  • Vivione Biosciences Inc.
Product Code: MRR-5012464363FE

The Rapid Microbiology Testing Market was valued at USD 4.86 billion in 2024 and is projected to grow to USD 5.22 billion in 2025, with a CAGR of 7.59%, reaching USD 7.54 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.86 billion
Estimated Year [2025] USD 5.22 billion
Forecast Year [2030] USD 7.54 billion
CAGR (%) 7.59%

Rapid microbiology testing has emerged as a transformative force in the realms of clinical diagnostics, environmental safety, industrial quality control, and pharmaceutical excellence. In today's fast-paced and precision-driven landscape, the emphasis on timely, accurate microbial detection has never been more pronounced. The evolution of microbiological techniques is not just a scientific pursuit-it is a strategic imperative for organizations striving to mitigate risks, streamline decision-making, and enhance productivity.

In this introduction, we set the stage by exploring the origins and rapid adoption of innovative microbiological methods. The need for accelerated testing procedures is driven by both emerging challenges in healthcare and the growing complexity of environmental and industrial matrices. The rapid technological advancements have not only shortened the turnaround times significantly but have also improved the reliability and sensitivity of detection systems. As we navigate this report, we delve into the nuances of these methodologies, shedding light on their applications and the competitive advantage they offer.

Technological improvements combined with real-time data analytics are revolutionizing how microbial testing is approached. The convergence of science and technology is fueling a shift towards methodologies that are both cost-effective and scalable, thereby benefiting a diverse spectrum of industries. This introductory section lays a solid foundation for understanding why rapid microbiology testing is indispensable in today's dynamic and interconnected world.

Transformative Shifts in the Rapid Microbiology Testing Landscape

The landscape of rapid microbiology testing has experienced a series of transformative shifts, driven by relentless innovation and evolving market demands. At the heart of these changes is the integration of advanced instrumentation and novel analytical techniques which have redefined the way microbial presence is detected and quantified.

Modern laboratories now benefit from state-of-the-art equipment that leverages automated systems and artificial intelligence to streamline workflows. Active air samplers and automated microbial identification systems have been pivotal in reducing manual intervention and increasing throughput. Systems such as bioluminescence and fluorescence-based detection, cytometers, mass spectrometers, and PCR platforms have set new benchmarks in sensitivity and specificity. The implementation of these advanced systems ensures that even minute microbial activities are identified, thereby enabling more precise diagnostic and preventative measures.

Beyond technological advancements, the broader market has also witnessed important paradigm shifts. The demand for faster, more efficient testing is propelling the industry to continually push boundaries. The market response has been characterized by strategic investments in research and development, fostering an environment where innovation is both encouraged and rewarded. This transformative phase is indicative of a larger move towards precision medicine and robust environmental, industrial, and quality assurance protocols.

The integration of digital transforms in lab operations, coupled with streamlined data analytics, has made it possible for researchers and practitioners to make more informed decisions. Collectively, these shifts underscore the dynamic nature of the industry as it continues to evolve in response to both technological advancements and market imperatives.

Key Segmentation Insights in the Rapid Microbiology Testing Market

A comprehensive understanding of market segmentation is critical for stakeholders aiming to capitalize on the evolving trends in rapid microbiology testing. The market is segmented along various dimensions, each offering unique insights into product innovations, testing methodologies, sample-specific challenges, particular applications, and the preferences of end users.

When analyzing based on product, the market is comprehensively studied across consumables, instruments, and reagents and kits. Instruments in particular are dissected further into several specialized categories. Active air samplers, automated microbial identification, and antimicrobial susceptibility testing systems provide crucial support in settings that require quick turnaround. There are also systems based on bioluminescence and fluorescence detection, along with cytometers and mass spectrometers that have driven advancements in microbial analysis. Moreover, PCR systems play an indispensable role by offering precision in genetic identification and amplification.

Testing methods provide another dimension of segmentation. The market exhibits significant differentiation among chromatography, mass spectrometry, and polymerase chain reaction techniques. Within chromatography, gas chromatography and liquid chromatography each cater to specific analytical needs, while mass spectrometry has further branches characterized by matrix-assisted laser desorption ionization and time-of-flight mass spectrometry, ensuring high sensitivity. The polymerase chain reaction is segmented further into digital PCR and real-time PCR, each designed to meet distinct objectives in microbial detection.

Segmentation based on sample type highlights the importance of context in microbial analysis. Commonly, testing is performed on blood, tissue, and urine samples, each presenting unique challenges and requirements. This segmentation underlines the need for tailored methodologies that address the intrinsic qualities of each sample type, thereby maximizing the accuracy of detection and ensuring robustness in results.

Application-based segmentation further demystifies the landscape by categorizing testing into clinical disease diagnostics, environmental testing, industrial testing, and pharmaceutical and biotechnology applications. Industrial testing itself is nuanced, with specific practices for cosmetics and personal care product testing, food and beverage testing, as well as pharmaceutical and biological drug testing. This multifaceted approach ensures that each application is addressed with the precision required by the respective industry standards.

The final segmentation based on the end user considers hospitals, laboratories, the manufacturing industry, and the public sector. Hospitals are further divided into private and public sectors, while laboratories include both clinical laboratories and research institutes. The manufacturing industry is analyzed with attention to food processors and pharmaceutical manufacturers, reflecting the diverse application of rapid microbiology testing across different operational paradigms.

These segmentation insights provide a granular view of the market and offer a roadmap for industry participants. By understanding the nuanced requirements across various segments, stakeholders are better positioned to innovate and strategically position their products and services. This detailed segmentation is instrumental in identifying areas of growth, understanding competitive dynamics, and tailoring solutions to meet the unique challenges of each segment.

Based on Product, market is studied across Consumables, Instruments, and Reagents & Kits. The Instruments is further studied across Active Air Samplers, Automated Microbial Identification & Antimicrobial Susceptibility Testing System, Bioluminescence & Fluorescence-Based Detection System, Cytometers, Mass Spectrometers, and PCR Systems.

Based on Testing Method, market is studied across Chromatography, Mass Spectrometry, and Polymerase Chain Reaction. The Chromatography is further studied across Gas Chromatography and Liquid Chromatography. The Mass Spectrometry is further studied across Matrix-Assisted Laser Desorption Ionization and Time-Of-Flight MS. The Polymerase Chain Reaction is further studied across Digital PCR and Real-Time PCR.

Based on Sample Type, market is studied across Blood, Tissue, and Urine.

Based on Application, market is studied across Clinical Disease Diagnostics, Environmental Testing, Industrial Testing, and Pharmaceutical & Biotechnology. The Industrial Testing is further studied across Cosmetics & Personal Care Products Testing, Food & Beverage testing, and Pharmaceutical & Biological Drug Testing.

Based on End User, market is studied across Hospitals, Laboratories, Manufacturing Industry, and Public Sector. The Hospitals is further studied across Private Hospitals and Public Hospitals. The Laboratories is further studied across Clinical Laboratories and Research Institutes. The Manufacturing Industry is further studied across Food Processors and Pharmaceutical Manufacturers.

Key Regional Insights in the Global Market

The rapid microbiology testing market exhibits distinctive regional dynamics, with varying trends and growth catalysts apparent across different geographies. In the Americas, robust investment in healthcare infrastructure and stringent regulatory frameworks are driving a surge in demand for rapid diagnostic tools. The region's focus on integration of advanced technological systems for timely and efficient testing underscores a broader commitment to enhancing public and private healthcare standards.

Across the Europe, Middle East & Africa regions, dynamic socio-economic conditions and evolving policy directives are shaping the market. Collaborative efforts in research and innovation, coupled with a keen focus on quality assurance in clinical settings, are propelling the adoption of rapid microbiology testing. The challenging regulatory environment in these regions has fostered a need for solutions that are both compliant and adaptable, further stimulating industry innovation.

Asia-Pacific is witnessing significant growth due to rapid urbanization, increasing healthcare budgets, and a surging demand for cost-effective diagnostic tools. This region's market is marked by expansive growth opportunities as investments in infrastructure and technology continue to rise. The local emphasis on integrating automation with traditional testing methodologies has accelerated the market's adoption across various sectors. As these regions continue to evolve, their distinct market drivers offer a complex but rich landscape for rapid microbiology testing technologies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Rapid Microbiology Testing Landscape

The industry is bolstered by the presence of several major companies that continue to shape the rapid microbiology testing landscape with cutting-edge technology and innovative solutions. Notable industry leaders include Abbott Laboratories, Becton, Dickinson and Company, and bioMerieux SA, all of which have a long-standing reputation for excellence in diagnostic solutions. Bruker Corporation, BTNX Inc., and Charles River Laboratories International, Inc. are also prominent, pushing forward with research and development initiatives that enhance testing efficiencies.

Companies such as Colifast AS and CorDx Inc, alongside industry giants like Danaher Corporation and Don Whitley Scientific Limited, are recognized for their contributions in refining microbial detection methodologies. Other key players, including Gradientech AB and Merck KGaA, consistently invest in advanced research to meet the evolving demands of the market. NEOGEN Corporation and Paragon Genomics, Inc. have also carved out significant niches, offering highly specialized solutions that cater to specific testing needs.

Further, PerkinElmer, Inc., Quidel Corporation, and R-Biopharm AG have garnered attention through their comprehensive portfolio of testing instruments and analytical techniques. The rapid evolution of this market is also reflected in the initiatives of companies like Rapid Micro Biosystems, Inc., rqmicro AG, and Sartorius AG, all of which are instrumental in setting new benchmarks for rapid and reliable testing. Additionally, Serosep Ltd., Thermo Fisher Scientific, Inc., and Vivione Biosciences Inc. are continuously innovating to deliver actionable insights and technologies that further the capabilities available in rapid microbiology testing. These companies not only drive technological advancements but also serve as benchmarks for quality, innovation, and customer trust in the industry.

The report delves into recent significant developments in the Rapid Microbiology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bruker Corporation, BTNX Inc., Charles River Laboratories International, Inc., Colifast AS, CorDx Inc, Danaher Corporation, Don Whitley Scientific Limited, Gradientech AB, Merck KGaA, NEOGEN Corporation, Paragon Genomics, Inc., PerkinElmer, Inc., Quidel Corporation, R-Biopharm AG, Rapid Micro Biosystems, Inc., rqmicro AG, Sartorius AG, Serosep Ltd., Thermo Fisher Scientific, Inc., and Vivione Biosciences Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to strategically position themselves by focusing on continuous innovation and robust market engagement. First, it is crucial for organizations to invest in research and development that targets the integration of automation, digital analytics, and high-throughput systems. By deploying next-generation sequencing technologies and enhanced mass spectrometric methodologies, companies can fine-tune their instruments for improved sensitivity and faster turnaround times.

Furthermore, staying current with regulatory compliance across different regional markets is paramount. Leaders should establish dedicated compliance teams that work in tandem with R&D departments to ensure that new technologies and testing approaches meet stringent regulatory standards. Leveraging partnerships with regional experts and regulatory consultants can support this initiative by providing nuanced insights into local compliance requirements.

Another key recommendation is to build a diversified portfolio that addresses a wide range of testing methods, sample types, and applications. By offering solutions that cater to clinical diagnostics, environmental testing, industrial quality assurance, and pharmaceutical processes, organizations can tap into multiple revenue streams. This diversified approach not only mitigates risk but also broadens market reach.

Further, direct engagement with end users through customized service packages and dedicated support channels can help in building long-term relationships and brand loyalty. Tailoring solutions to meet the specific needs of hospitals, laboratories, manufacturing industries, and public sector organizations is essential. Proactive client engagement initiatives, such as hands-on workshops, user training sessions, and roundtable discussions, are valuable in gathering user feedback and driving subsequent innovation.

Leveraging strategic geographic expansion is another actionable recommendation. Companies should analyze regional trends carefully and consider establishing localized centers of excellence. Such centers can serve as hubs for research, development, and customer support, thereby facilitating a deeper understanding of regional market dynamics and faster deployment of solutions.

Finally, fostering a culture of collaboration both internally and externally can yield significant benefits. Partnership with academic institutions, collaborative research consortia, and cross-industry innovation hubs can spur breakthroughs that translate into more efficient and cost-effective rapid microbiology testing solutions. This multi-faceted approach will enable industry leaders to not only adapt to current market trends but also set the pace for future developments.

Conclusion: Embracing a New Era in Microbiology Testing

In conclusion, the future of rapid microbiology testing is characterized by innovation, precision, and a commitment to quality. The integration of advanced technologies, coupled with comprehensive market segmentation, has redefined how microbial detection is approached across various industries. By analyzing the market from multiple perspectives-be it product lines, testing methodologies, sample types, application areas, or end user demands-the industry is poised to offer solutions that are both groundbreaking and deeply practical.

The regional dynamics further underscore the varied yet interconnected growth opportunities around the globe. With robust markets in the Americas, Europe, Middle East & Africa, and Asia-Pacific, there is a clear mandate for localized strategies that address unique regional demands. Companies that can navigate these nuanced landscapes while adhering to global standards are well-positioned to lead in this transformative era.

Moreover, the industry is supported by a suite of dynamic companies that continue to drive innovation and set new standards for rapid, reliable testing. The collective efforts of these organizations have paved the way for a future where diagnostic testing is not just fast but exceedingly precise. As we reflect on the current state and future prospects of rapid microbiology testing, it becomes evident that the journey ahead is filled with promising opportunities for growth and advancement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of rapid microbiology testing for clinical diagnosis of infectious diseases
      • 5.1.1.2. Rapid adoption in industrial and environmental testing applications
      • 5.1.1.3. Strict government standards for food and water testing
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with rapid microbiology testing kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing point-of-care rapid microbiological tests for telehealth and remote diagnostics
      • 5.1.3.2. Integration of AI-driven analytics in rapid microbiological testing for enhanced accuracy
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations associated with rapid microbial testing solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Testing Method: Proliferating use of chromatography testing method for separating chemical mixtures
    • 5.2.2. End User: Expanding utilization of rapid microbiology testing in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Rapid Microbiology Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
    • 6.3.1. Active Air Samplers
    • 6.3.2. Automated Microbial Identification & Antimicrobial Susceptibility Testing System
    • 6.3.3. Bioluminescence & Fluorescence-Based Detection System
    • 6.3.4. Cytometers
    • 6.3.5. Mass Spectrometers
    • 6.3.6. PCR Systems
  • 6.4. Reagents & Kits

7. Rapid Microbiology Testing Market, by Testing Method

  • 7.1. Introduction
  • 7.2. Chromatography
    • 7.2.1. Gas Chromatography
    • 7.2.2. Liquid Chromatography
  • 7.3. Mass Spectrometry
    • 7.3.1. Matrix-Assisted Laser Desorption Ionization
    • 7.3.2. Time-Of-Flight MS
  • 7.4. Polymerase Chain Reaction
    • 7.4.1. Digital PCR
    • 7.4.2. Real-Time PCR

8. Rapid Microbiology Testing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Tissue
  • 8.4. Urine

9. Rapid Microbiology Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Disease Diagnostics
  • 9.3. Environmental Testing
  • 9.4. Industrial Testing
    • 9.4.1. Cosmetics & Personal Care Products Testing
    • 9.4.2. Food & Beverage testing
    • 9.4.3. Pharmaceutical & Biological Drug Testing
  • 9.5. Pharmaceutical & Biotechnology

10. Rapid Microbiology Testing Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Laboratories
    • 10.3.1. Clinical Laboratories
    • 10.3.2. Research Institutes
  • 10.4. Manufacturing Industry
    • 10.4.1. Food Processors
    • 10.4.2. Pharmaceutical Manufacturers
  • 10.5. Public Sector

11. Americas Rapid Microbiology Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Rapid Microbiology Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Rapid Microbiology Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Oculer gains AOAC approval, boosting rapid microbiology testing for UHT milk
    • 14.3.2. bioMerieux and AnaBioTec partner to accelerate rapid mycoplasma testing for enhanced biopharma and CGT efficiency
    • 14.3.3. Samsung and Rapid Micro Biosystems partner to deploy Growth Direct platform
    • 14.3.4. The Forge of Collaborative Innovation in Microbial Testing Elevating Pharmaceutical Standards

14.3.5. Enhancing Advanced Therapies through Swift Microbial Testing:

  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. bioMerieux SA
  • 4. Bruker Corporation
  • 5. BTNX Inc.
  • 6. Charles River Laboratories International, Inc.
  • 7. Colifast AS
  • 8. CorDx Inc
  • 9. Danaher Corporation
  • 10. Don Whitley Scientific Limited
  • 11. Gradientech AB
  • 12. Merck KGaA
  • 13. NEOGEN Corporation
  • 14. Paragon Genomics, Inc.
  • 15. PerkinElmer, Inc.
  • 16. Quidel Corporation
  • 17. R-Biopharm AG
  • 18. Rapid Micro Biosystems, Inc.
  • 19. rqmicro AG
  • 20. Sartorius AG
  • 21. Serosep Ltd.
  • 22. Thermo Fisher Scientific, Inc.
  • 23. Vivione Biosciences Inc.

LIST OF FIGURES

  • FIGURE 1. RAPID MICROBIOLOGY TESTING MARKET MULTI-CURRENCY
  • FIGURE 2. RAPID MICROBIOLOGY TESTING MARKET MULTI-LANGUAGE
  • FIGURE 3. RAPID MICROBIOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 4. RAPID MICROBIOLOGY TESTING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. RAPID MICROBIOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. RAPID MICROBIOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RAPID MICROBIOLOGY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ACTIVE AIR SAMPLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION IONIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TIME-OF-FLIGHT MS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PUBLIC SECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 307. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA